{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:11:48Z","timestamp":1790230308432,"version":"4.1.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1097\/hrp.0000000000000063","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T10:17:35Z","timestamp":1425637055000},"page":"90-98","source":"Crossref","is-referenced-by-count":83,"title":["Treatment of Tobacco Use Disorders in Smokers with Serious Mental Illness"],"prefix":"10.1097","volume":"23","author":[{"given":"A. Eden","family":"Evins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Cather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Laffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-4-20210129","first-page":"29","article-title":"Current cigarette smoking among adultsUnited States, 2005-2012.","volume":"63","author":"Agaku","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.2013.284985","article-title":"Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation.","volume":"311","author":"Cook","year":"2014","journal-title":"JAMA"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2105\/AJPH.2009.188136","article-title":"Smoking characteristics of adults with selected lifetime mental illnesses: results from the 2007 National Health Interview Survey.","volume":"100","author":"McClave","year":"2010","journal-title":"Am J Public Health"},{"key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ps.201200143","article-title":"Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011.","volume":"64","author":"Dickerson","year":"2013","journal-title":"Psychiatr Serv"},{"key":"R6-4-20210129","first-page":"248","article-title":"Comorbidity of severe psychotic disorders with measures of substance use.","volume":"71","author":"Hartz","year":"2014","journal-title":"JAMA"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.comppsych.2011.04.063","article-title":"Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients.","volume":"53","author":"Kreinin","year":"2012","journal-title":"Compr Psychiatry"},{"issue":"34","key":"R8-4-20210129","first-page":"1","article-title":"Depression and smoking in the U.S. household population aged 20 and over, 2005-2008.","author":"Pratt","year":"2010","journal-title":"NCHS Data Brief"},{"key":"R10-4-20210129","first-page":"A42","article-title":"Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.","volume":"3","author":"Colton","year":"2006","journal-title":"Prev Chronic Dis"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","article-title":"Actual causes of death in the United States, 2000.","volume":"291","author":"Mokdad","year":"2004","journal-title":"JAMA"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"e1000058","DOI":"10.1371\/journal.pmed.1000058","article-title":"The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors.","volume":"6","author":"Danaei","year":"2009","journal-title":"PLoS Med"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpsychires.2013.09.014","article-title":"Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression.","volume":"48","author":"Callaghan","year":"2014","journal-title":"J Psychiatr Res"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(12)61720-6","article-title":"The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK.","volume":"381","author":"Pirie","year":"2013","journal-title":"Lancet"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMsa1211128","article-title":"21st-century hazards of smoking and benefits of cessation in the United States.","volume":"368","author":"Jha","year":"2013","journal-title":"N Engl J Med"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.publhealth.012809.103701","article-title":"Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems.","volume":"31","author":"Schroeder","year":"2010","journal-title":"Annu Rev Public Health"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.schres.2009.09.032","article-title":"Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls.","volume":"115","author":"Tidey","year":"2009","journal-title":"Schizophr Res"},{"key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2105\/AJPH.2005.080382","article-title":"Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial.","volume":"96","author":"Hall","year":"2006","journal-title":"Am J Public Health"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2105\/AJPH.2006.101147","article-title":"Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning.","volume":"98","author":"Prochaska","year":"2008","journal-title":"Am J Public Health"},{"key":"R20-4-20210129","first-page":"CD007253","article-title":"Interventions for smoking cessation and reduction in individuals with schizophrenia.","volume":"2","author":"Tsoi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R21-4-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr Bull"},{"key":"R22-4-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-3223(02)01339-2","article-title":"A placebo controlled trial of bupropion for smoking cessation in schizophrenia.","volume":"52","author":"George","year":"2002","journal-title":"Biol Psychiatry"},{"key":"R23-4-20210129","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.jcp.0000162802.54076.18","article-title":"A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.","volume":"25","author":"Evins","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R24-4-20210129","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.jcp.0b013e3180ca86fa","article-title":"A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.","volume":"27","author":"Evins","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R25-4-20210129","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.biopsych.2007.11.002","article-title":"A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.","volume":"63","author":"George","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R26-4-20210129","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4088\/JCP.11m07522","article-title":"A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.","volume":"73","author":"Williams","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"R27-4-20210129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.schres.2011.02.003","article-title":"Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study.","volume":"129","author":"Weiner","year":"2011","journal-title":"Schizophr Res"},{"key":"R28-4-20210129","first-page":"CD006102","article-title":"Smoking cessation interventions for smokers with current or past depression.","volume":"8","author":"van der Meer","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R29-4-20210129","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-159-6-201309170-00005","article-title":"Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.","volume":"159","author":"Anthenelli","year":"2013","journal-title":"Ann Intern Med"},{"key":"R30-4-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/15504263.2012.749559","article-title":"An open trial of relapse prevention therapy for smokers with schizophrenia.","volume":"9","author":"Cather","year":"2013","journal-title":"J Dual Diagn"},{"key":"R31-4-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.2013.285113","article-title":"Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.","volume":"311","author":"Evins","year":"2014","journal-title":"JAMA"},{"key":"R32-4-20210129","first-page":"349","article-title":"Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia.","volume":"1","author":"Horst","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R33-4-20210129","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1176\/appi.ajp.2013.13091257","article-title":"Reassessing the safety of varenicline.","volume":"170","author":"Evins","year":"2013","journal-title":"Am J Psychiatry"},{"key":"R35-4-20210129","first-page":"29422","article-title":"Final notice establishing definitions for (1) children with a serious emotional disturbance, and (2) adults with a serious mental illness.","volume":"58","year":"1993","journal-title":"Federal Regist"},{"key":"R36-4-20210129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archpsyc.60.2.184","article-title":"Screening for serious mental illness in the general population.","volume":"60","author":"Kessler","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R37-4-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.2013.283787","article-title":"Pharmacological treatments for smoking cessation.","volume":"311","author":"Cahill","year":"2014","journal-title":"JAMA"},{"key":"R38-4-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-9964(01)00217-1","article-title":"Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders.","volume":"56","author":"de Leon","year":"2002","journal-title":"Schizophr Res"},{"key":"R39-4-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(96)00302-2","article-title":"Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.","volume":"42","author":"Olincy","year":"1997","journal-title":"Biol Psychiatry"},{"key":"R40-4-20210129","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.schres.2005.04.016","article-title":"Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect.","volume":"79","author":"Williams","year":"2005","journal-title":"Schizophr Res"},{"key":"R41-4-20210129","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","article-title":"Smoking and mental illness: a population-based prevalence study.","volume":"284","author":"Lasser","year":"2000","journal-title":"JAMA"},{"key":"R42-4-20210129","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1360-0443.2009.02545.x","article-title":"Assessing motivation to quit smoking in people with mental illness: a review.","volume":"104","author":"Siru","year":"2009","journal-title":"Addiction"},{"key":"R43-4-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/070674379704200107","article-title":"Readiness to stop smoking in schizophrenia.","volume":"42","author":"Addington","year":"1997","journal-title":"Can J Psychiatry"},{"key":"R44-4-20210129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","article-title":"Causes of the excess mortality of schizophrenia.","volume":"177","author":"Brown","year":"2000","journal-title":"Br J Psychiatry"},{"key":"R45-4-20210129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4088\/JCP.v66n0205","article-title":"Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists.","volume":"66","author":"Goff","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R46-4-20210129","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14622200110073920","article-title":"A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.","volume":"3","author":"Evins","year":"2001","journal-title":"Nicotine Tob Res"},{"key":"R47-4-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4088\/JCP.10m06143gre","article-title":"Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.","volume":"73","author":"Weiner","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"R48-4-20210129","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1176\/appi.ajp.161.11.2100","article-title":"Extended nortriptyline and psychological treatment for cigarette smoking.","volume":"161","author":"Hall","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R49-4-20210129","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thorax.55.12.987","article-title":"Smoking cessation guidelines for health professionals: an update. Health Education Authority.","volume":"55","author":"West","year":"2000","journal-title":"Thorax"},{"key":"R50-4-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15504263.2012.663675","article-title":"Varenicline for smoking cessation in schizophrenia: safety and effectiveness in a 12-week, open-label trial.","volume":"8","author":"Pachas","year":"2012","journal-title":"J Dual Diagn"},{"key":"R51-4-20210129","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1176\/appi.ajp.2013.12121599","article-title":"Varenicline, smoking cessation, and neuropsychiatric adverse events.","volume":"170","author":"Gibbons","year":"2013","journal-title":"Am J Psychiatry"},{"key":"R52-4-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/15504263.2012.671717","article-title":"A review of smoking cessation in bipolar disorder: implications for future research.","volume":"8","author":"George","year":"2012","journal-title":"J Dual Diagn"},{"key":"R53-4-20210129","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-5618.2011.00943.x","article-title":"The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations.","volume":"13","author":"Heffner","year":"2011","journal-title":"Bipolar Disord"},{"key":"R54-4-20210129","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/JCP.0b013e318184ba3c","article-title":"A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder.","volume":"28","author":"Weinberger","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R55-4-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/15504263.2012.671067","article-title":"A preliminary feasibility study of varenicline for smoking cessation in bipolar disorder.","volume":"8","author":"Wu","year":"2012","journal-title":"J Dual Diagn"},{"key":"R56-4-20210129","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4088\/JCP.13m08756","article-title":"Varenicline for smoking cessation in bipolar disorder: a randomised, double-blind, placebo-controlled study.","volume":"75","author":"Chengappa","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"R57-4-20210129","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1399-5618.2011.00944.x","article-title":"An online survey of tobacco use, intentions to quit, and cessation strategies among people living with bipolar disorder.","volume":"13","author":"Prochaska","year":"2011","journal-title":"Bipolar Disord"},{"key":"R58-4-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1399-5618.2012.00985.x","article-title":"Cigarette smoking and its relationship to mood disorder symptoms and co-occurring alcohol and cannabis use disorders following first hospitalization for bipolar disorder.","volume":"14","author":"Heffner","year":"2012","journal-title":"Bipolar Disord"},{"key":"R59-4-20210129","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1037\/0022-006X.62.1.141","article-title":"Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers.","volume":"62","author":"Hall","year":"1994","journal-title":"J Consult Clin Psychol"},{"key":"R60-4-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0306-4603(01)00266-0","article-title":"Onset of major depression during treatment for nicotine dependence.","volume":"28","author":"Killen","year":"2003","journal-title":"Addict Behav"},{"key":"R61-4-20210129","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ntr\/nts213","article-title":"Two decades of smoking cessation treatment research on smokers with depression: 1990-2010.","volume":"15","author":"Weinberger","year":"2013","journal-title":"Nicotine Tob Res"},{"key":"R62-4-20210129","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archgenpsychiatry.2009.142","article-title":"A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.","volume":"66","author":"Piper","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"R63-4-20210129","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","article-title":"Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.","volume":"157","author":"George","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R64-4-20210129","first-page":"215","article-title":"The impact of smoking cessation programs on smoking-related health beliefs and rate of quit-smoking among schizophrenic patients.","volume":"22","author":"Chen","year":"2002","journal-title":"J Med Sci"},{"key":"R65-4-20210129","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1176\/ajp.2006.163.11.1934","article-title":"A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder.","volume":"163","author":"Baker","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R66-4-20210129","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ypmed.2011.11.010","article-title":"Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness.","volume":"55 ssuppl","author":"Tidey","year":"2012","journal-title":"Prev Med"},{"key":"R67-4-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-011-2282-8","article-title":"Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia.","volume":"217","author":"Tidey","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"R68-4-20210129","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11606-011-1915-2","article-title":"Smoking cessation interventions for patients with depression: a systematic review and meta-analysis.","volume":"27","author":"Gierisch","year":"2012","journal-title":"J Gen Intern Med"},{"key":"R69-4-20210129","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00003088-199936060-00004","article-title":"Drug interactions with tobacco smoking. An update.","volume":"36","author":"Zevin","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"R70-4-20210129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s002280050394","article-title":"A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers.","volume":"53","author":"Schrenk","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"R71-4-20210129","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0010-440X(90)90042-Q","article-title":"Depression and depressive symptoms in smoking cessation.","volume":"31","author":"Covey","year":"1990","journal-title":"Compr Psychiatry"},{"key":"R72-4-20210129","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.1990.03450120058029","article-title":"Smoking, smoking cessation, and major depression.","volume":"264","author":"Glassman","year":"1990","journal-title":"JAMA"},{"key":"R73-4-20210129","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(00)05064-9","article-title":"Smoking cessation and the course of major depression: a follow-up study.","volume":"357","author":"Glassman","year":"2001","journal-title":"Lancet"},{"key":"R74-4-20210129","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1176\/appi.ajp.157.3.368","article-title":"Development of major depression after treatment for smoking cessation.","volume":"157","author":"Tsoh","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R75-4-20210129","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1037\/0021-843X.111.4.670","article-title":"Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder.","volume":"111","author":"Kahler","year":"2002","journal-title":"J Abnorm Psychol"},{"key":"R76-4-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S0033291709990560","article-title":"Quitting smoking does not increase the risk of major depressive episodes among users of Internet smoking cessation interventions.","volume":"40","author":"Torres","year":"2010","journal-title":"Psychol Med"},{"key":"R77-4-20210129","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/ijerph10020446","article-title":"Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study.","volume":"10","author":"Caponnetto","year":"2013","journal-title":"Int J Environ Res Public Health"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HRP.0000000000000063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:44:44Z","timestamp":1620953084000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00023727-201503000-00004"}},"subtitle":["Toward Clinical Best Practices"],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/hrp.0000000000000063","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}